Home » Topics » Regulatory » Patents

Patents
RSS

Joint effort between Eisai and Epizyme results in new EZH2 inhibitors

Nov. 14, 2012

Novartis discloses novel prodrugs of SGLT1/2 inhibitors

Nov. 14, 2012

Otsuka Pharmaceutical patents new antibacterial agents

Nov. 14, 2012

Researchers divulge new SERMs for the treatment of breast cancer

Nov. 14, 2012

AstraZeneca presents novel PI3K inhibitors

Nov. 14, 2012

Teknologian Tutkimuskeskus patents new pollen allergen polypeptides

Nov. 14, 2012

Novel enhancers of SMN2 expression presented by AMRI and HHS

Nov. 14, 2012

Laboratoire Biodim prepares new anti-HIV agents

Nov. 13, 2012

Bayer Intellectual Property divulges novel GCS activators

Nov. 13, 2012

New S1P1 receptor agonists presented by French and Indian researchers

Nov. 13, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...